Hot climates worsen chronic kidney disease outcomes

FHS
April 6, 2024
3:07 am

Chronic kidney disease patients living in the hottest countries experienced an additional 8% drop in kidney function each year compared to those living in temperate climates, finds a new study from researchers at UCL and the London School of Hygiene & Tropical Medicine (LSHTM).

Bayer wins FDA breakthrough therapy designation for NSCLC candidate – Pharmaceutical Technology

Share this article Bayer is now eligible to receive fast track benefits and added guidance from the agency for the drug’s development plan, as per

February 26, 2024

Intra-Cellular bolsters Caplyta data with another Phase III win

Intra-Cellular expects Caplyta to rake in about $665-685m in sales this year. Image credit: Lightspring / Shutterstock. Having raised the full-year sales guidance for Caplyta

November 6, 2024

Should I Offer My Patient the Option to End His Life?

Listen and subscribe/follow on Apple and Spotify so you don’t miss the next episode. And if you like what you hear, a five-star rating goes

October 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.